Bernatchez
Chantale Bernatchez, Spring, TX US
Patent application number | Description | Published |
---|---|---|
20130302300 | B AND T LYMPHOCYTE ATTENUATOR MARKER FOR USE IN ADOPTIVE T-CELL THERAPY - BTLA-positive (“BTLA+”) lymphocyte signaling drives T cells and kills tumors. BTLA functions as a positive modulator of anti-tumor (anti-melanoma) T cell responses, The BTLA+ T cell responds against tumor or cancer cells, and, in cancer patients respond better to IL-2 than BTLA-negative cells. Hence, the BTLA-positive T cell in cancers is a positive marker for selection of enriched anti-tumor-cancer reactive T cells and can be used or applied for adoptive T-cell therapy or for therapeutic purposes. | 11-14-2013 |
Georges-André Bernatchez, St-Augustin-De-Desmaures CA
Patent application number | Description | Published |
---|---|---|
20120090528 | PERSONAL SECURITY KEY HOLDER - A key holder for personal security including a L-shaped body having a main elongated portion and a secondary elongated portion joined to the main elongated portion at a junction end of the main elongated portion, the secondary elongated portion being one of equal and shorter than the main elongated portion; an enlarged head at a head end of the secondary elongated portion, the enlarged head being larger than a width of the secondary elongated portion, the head end being opposed to the junction end; a key attachment provided on an outside of the junction end, the key attachment adapted to attach keys to the key holder, the secondary elongated portion being adapted to be received between two fingers of a single hand of a user, the main elongated portion being adapted to be received in a palm of the single hand. Additionally, a whistle can be provided at a whistle end of the main elongated portion, the whistle end being opposed to the junction end. Additionally, a light can be provided on the enlarged head. | 04-19-2012 |
Hannah Bernatchez, Ottawa CA
Patent application number | Description | Published |
---|---|---|
20130045477 | DIRECT NUCLEIC ACID ANALYSIS - Methods and apparatus are described for nucleic acid analysis of swab samples without the need for purification. | 02-21-2013 |
Michel Bernatchez, Montreal CA
Patent application number | Description | Published |
---|---|---|
20090099376 | TIGECYCLINE AND METHODS OF PREPARING INTERMEDIATES - Methods of preparing and purifying 9-nitrominocycline and 9-aminominocycline and salts thereof used in the process of making tigecycline, are disclosed. In one embodiment, the invention is directed to a method of preparing the compound of formula 1 | 04-16-2009 |
20090192311 | CRYSTALLINE AND AMORPHOUS 4-CYANO-N--N-PYRIDIN-2-YL-BENZAMIDE HYDROCHLORIDE - The present invention is directed to crystal and amorphous forms of the 5-HT | 07-30-2009 |
Stephane Bernatchez, Chelsea CA
Patent application number | Description | Published |
---|---|---|
20110111454 | ENGINEERED VERSIONS OF CgtB (Beta-1,3 GALACTOSYLTRANSFERASE) ENZYMES, WITH ENHANCED ENZYMATIC PROPERTIES - CgtB proteins with enhanced beta 1,3-galactosaminyltransferase activity, nucleic acids that encode the CgtB proteins and methods for use of the CgtB proteins. | 05-12-2011 |
Stephanie F. Bernatchez, Woodbury, MN US
Patent application number | Description | Published |
---|---|---|
20100273666 | METHODS OF ANALYZING WOUND SAMPLES - A method of analyzing wound samples is provided. The analysis typically involves the use of mass spectrometry. | 10-28-2010 |
20110151000 | NITRIC OXIDE-RELEASING COMPOSITIONS, DEVICES AND METHODS - Nitric oxide releasing compositions, which comprise nanoparticles having an exterior surface comprising solid amorphous silica, the exterior surface having nitrosothiol-containing groups attached thereto, the nanoparticles being dispersible in an aqueous system, devices including the compositions, and methods of making and using the compositions and devices are disclosed. | 06-23-2011 |
20120135444 | SAMPLING DEVICES AND METHODS OF USE - The present disclosure provides devices and rapid methods to acquire a wound sample to detect the presence of NO | 05-31-2012 |
20150072966 | METHOD OF PROMOTING WOUND HEALING - A method of establishing a therapeutic window of wound fluid nitric oxide (WFNO) in the wound of a mammal, the method including: obtaining a wound fluid sample from a mammal; analyzing the WFNO level; determining whether the WFNO is at or below a lower threshold level, or is at or above an upper threshold level; wherein the lower threshold level and upper threshold level define the therapeutic window of WFNO; and treating the mammal with a substance that alters the WFNO level such that the therapeutic window of WFNO in the wound is established. | 03-12-2015 |